Possible neuromarker for 'juvenile-onset' Batten disease
Researchers find that an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials in Batten disease.
http://dlvr.it/T171gD
http://dlvr.it/T171gD
Yorumlar
Yorum Gönder